Home > > > > Report Detail

United States Anesthesia Drugs Market, By Type (Local, General Inhalation, General Intravenous) & Companies

Publisher Name :
Date: 08-Jun-2018
No. of pages: 136
Inquire Before Buying

Anesthesia is a medicine which is given to relieve pain and sensation during surgery. Drugs render a patient unresponsive and unconscious. United States Anesthesia Drugs Market is projected to reach US$ 5 Billion by the year 2024 owing to the increasing prevalence of cardiovascular cases, rising geriatric population and growing number of urgent surgeries in the United States. The different types of anesthesia are Local Anesthesia, General Inhalation Anesthesia and General Intravenous Anesthesia. Local Anesthesia and General Anesthesia are the two commonly used types of anesthesia. Local anesthesia is a condition when sensation within a specific body part in inhibited, where as general anesthesia results in loss of consciousness and sensation. Furthermore, the public and private health insurers’ consideration of adding anesthetic products in their reimbursement policy is expected to boost the US anesthesia drugs market in the recent years.

All Major Companies Losing their Market Share

In United States all established companies are losing their market share. Primarily because anesthesia drugs are mostly sold in generic form as it is available in the low cost. The companies studied in the report are Baxter International Inc, Endo International plc & AbbVie. Today, with the help of anesthesia medical facilities, performs various surgeries to treat patient’s deformities in the field of trauma, cardiovascular, gastrointestinal, urological, orthopedics, ophthalmology, neurology, oncology and cosmetics.

Renub Research report titled “United States Anesthesia Drugs Market, By Type [General Inhalation Anesthesia, General Intravenous Anesthesia (Propofol, Benzodiazepines Class, Fospropofol Disodium, Ketamine, Methohexital Sodium, Pentobarbital, Etomidate & Fentanyl) and Local Anesthesia (Articaine, Bupivacaine, Lidocaine, Mepivacaine & Prilocaine], Companies (Baxter International, Endo International plc, AbbVie & Others)” provides a complete analysis of United States Anesthesia Drugs Market.

By Type – General Intravenous Anesthesia leads the Market but Local Anesthesia Drugs is the Future

The report studies the market of the following Anesthesia Drugs segments: General Inhalation Anesthesia, General Intravenous Anesthesia can be further subdivided into (Propofol, Benzodiazepines Class, Fospropofol Disodium, Ketamine, Methohexital Sodium, Pentobarbital, Etomidate & Fentanyl),  Among these anesthesia, Propofol and Benzodiazepines Class are the leading anesthesia drugs. Local Anesthesia is further segmented into (Articaine, Bupivacaine, Lidocaine, Mepivacaine & Prilocaine). Among these Articaine and Lidocaine have good market share.   

Companies Analysis

Baxter International, Endo International plc, and AbbVie are some of the top companies operating in the United States Anesthesia Drugs Market; which has been studied thoroughly in the report.

This market research report provides a complete analysis of the United States Anesthesia Drugs Market and their projections for the upcoming years, Growth Drivers, Challenges, and Reimbursement policy.  

By Type - United States Anesthesia Drugs Market

1.    General Inhalation Anesthesia

2.    General Intravenous Anesthesia

•    Propofol
•    Benzodiazepines Class
•    Fospropofol Disodium
•    Ketamine
•    Methohexital Sodium
•    Pentobarbital
•    Etomidate
•    Fentanyl

 

3.    Local Anesthesia

•    Articaine
•    Bupivacaine
•    Lidocaine
•    Mepivacaine
•    Prilocaine

Key Players Sales - United States Anesthetic Drugs Market

1.    Baxter International Inc
2.    Endo International plc
3.    AbbVie

This Report provides the answer of following Questions:

    What will be the United States Anesthesia Drugs Market by 2024?
    What will be the United States Local Anesthesia Drugs Market for the year 2024?
    What was the United States General Inhalation Anesthesia Drugs Market in 2017?
    Among General Inhalation, General Intravenous and Local Anesthesia; which one is driving the United States Anesthesia Drugs Market?
    What are the key driving forces for United States Anesthesia Drugs Market?
    What are the key challenges to United States Anesthesia Drugs Market?

United States Anesthesia Drugs Market, By Type (Local, General Inhalation, General Intravenous) & Companies

Table of Contents

1. Executive Summary

2. United States Anesthesia Drugs Market

3. Market Share – United States Anesthesia Drugs

3.1 Anesthesia Drugs
3.2 General Intravenous Anesthesia Drugs
3.3 Local Anesthesia Drugs
3.4 Company

4. Market – United States Anesthesia Drugs Types

4.1 General Inhalation Anesthesia Drugs Market
4.2 General Intravenous Anesthesia Drugs Market
4.3 Local Anesthesia Drugs Market

5. Market – General Intravenous Anesthesia Drugs

5.1 Propofol
5.2 Benzodiazepines Class (Diazepam and Midazolam)
5.3 Fospropofol Disodium
5.4 Ketamine
5.5 Methohexital Sodium
5.6 Pentobarbital
5.7 Etomidate
5.8 Fentanyl

6. Market – Local Anesthesia Drugs

6.1 Articaine
6.2 Bupivacaine
6.3 Lidocaine
6.4 Mepivacaine
6.5 Prilocaine

7. Companies - United States Anesthesia Drugs Market

7.1 Baxter International Inc. Anesthesia Drugs Sales
7.2 Endo International plc Anesthesia Drugs Sales
7.3 AbbVie Anesthesia Drugs Sales
7.4 Other Companies Anesthetic Drugs Sales

8. Merger & Acquisition (M&A) – United States Anesthesia

9. Reimbursement Policy - Private Health Insurance Providers

9.1 Aetna International
9.2 Coventry Health Care
9.3 Anthem Blue Cross and Blue Shield
9.4 Blue Cross and Blue Shield of Texas
9.5 United Healthcare

9.5.1 State Exceptions

10. Reimbursement Policy – Public Health Insurance Providers

10.1 Medicare
10.2 MDWise

11. Growth Drivers

11.1 Growing Demand for Anesthesia Service
11.2 Rise in Ageing Population & Prevalence of Cardiovascular Disease in United States

12. Challenges

12.1 Un-match Anesthesia Providers in United States
12.2 Shortage of Anesthesia Drugs in United States  

List of Figures:

Figure 2‑1: United States – Anesthesia Drugs Market (Million US$), 2011 – 2017
Figure 2‑2: United States – Forecast for Anesthesia Drugs Market (Million US$), 2018 – 2024

Figure 3‑1: United States – Anesthesia Drugs Market Share by Type (Percent), 2011 – 2017
Figure 3‑2: United States – Forecast for Anesthesia Drugs Market Share by Type (Percent), 2018 – 2024
Figure 3‑3: United States – General Intravenous Anesthesia Drugs Market Share (Percent), 2011 – 2017
Figure 3‑4: United States – Forecast for General Intravenous Anesthesia Drugs Market Share (Percent), 2018 – 2024
Figure 3‑5: United States – Local Anesthesia Drugs Market Share (Percent), 2011 – 2017
Figure 3‑6: United States – Forecast for Local Anesthesia Drugs Market Share (Percent), 2018 – 2024
Figure 3‑7: United States – Anesthesia Drugs Market Share by Company (Percent), 2011 – 2017
Figure 3‑8: United States – Forecast for Anesthesia Drugs Market Share by Company (Percent), 2018 – 2024

Figure 4‑1: United States – General Inhalation Anesthesia Drugs Market (Million US$), 2011-2017
Figure 4‑2: United States – Forecast for General Inhalation Anesthesia Drugs Market (Million US$), 2018 – 2024
Figure 4‑3: United States – General Intravenous Anesthesia Drugs Market (Million US$), 2011 – 2017
Figure 4‑4: United States – Forecast for General Intravenous Anesthesia Drugs Market (Million US$), 2018 – 2024
Figure 4‑5: United States – Local Anesthesia Drugs Market (Million US$), 2011-2017
Figure 4‑6: United States – Forecast for Local Anesthesia Drugs Market (Million US$), 2018 – 2024

Figure 5‑1: United States – Propofol Market (Million US$), 2011 – 2017
Figure 5‑2: United States – Forecast for Propofol Market (Million US$), 2018 – 2024
Figure 5‑3: United States – Benzodiazepines Class Market (Million US$), 2011 – 2017
Figure 5‑4: United States – Forecast for Benzodiazepines Class Market (Million US$), 2018 – 2024
Figure 5‑5: United States – Fospropofol Disodium Market (Million US$), 2011 – 2017
Figure 5‑6: United States – Forecast for Fospropofol Disodium Market (Million US$), 2018 – 2024
Figure 5‑7: United States – Ketamine Market (Million US$), 2011 – 2017
Figure 5‑8: United States – Forecast for Ketamine Market (Million US$), 2018 – 2024
Figure 5‑9: United States – Methohexital Sodium Market (Million US$), 2011 – 2017
Figure 5‑10: United States – Forecast for Methohexital Sodium Market (Million US$), 2018 – 2024
Figure 5‑11: United States – Pentobarbital Market (Million US$), 2011 – 2017
Figure 5‑12: United States – Forecast for Pentobarbital Market (Million US$), 2018 – 2024
Figure 5‑13: United States – Etomidate Market (Million US$), 2011 – 2017
Figure 5‑14: United States – Forecast for Etomidate Market (Million US$), 2018 – 2024
Figure 5‑15: United States – Fentanyl Market (Million US$), 2011 – 2017
Figure 5‑16: United States – Forecast for Fentanyl Market (Million US$), 2018 – 2024
Figure 6‑1: United States – Articaine Market (Million US$), 2011-2017
Figure 6‑2: United States – Forecast for Articaine Market (Million US$), 2018 – 2024
Figure 6‑3: United States – Bupivacaine Market (Million US$), 2011-2017
Figure 6‑4: United States – Forecast for Bupivacaine Market (Million US$), 2018 – 2024
Figure 6‑5: United States – Lidocaine Market (Million US$), 2011-2017
Figure 6‑6: United States – Forecast for Lidocaine Market (Million US$), 2018 – 2024
Figure 6‑7: United States – Mepivacaine Market (Million US$), 2011-2017
Figure 6‑8: United States – Forecast for Mepivacaine Market (Million US$), 2018 – 2024
Figure 6‑9: United States – Prilocaine Market (Million US$), 2011-2017
Figure 6‑10: United States – Forecast for Prilocaine Market (Million US$), 2018 – 2024
Figure 7‑1: United States – Baxter International Anesthesia Drugs Sales (Million US$), 2011-2017
Figure 7‑2: United States – Forecast for Baxter International Anesthesia Drugs Sales (Million US$), 2018 – 2024
Figure 7‑3: United States – Endo International plc Anesthesia Drugs Sales (Million US$), 2011-2017
Figure 7‑4: United States – Forecast for Endo International plc Anesthesia Drugs Sales (Million US$), 2018 – 2024
Figure 7‑5: United States – AbbVie Anesthesia Drugs Sales (Million US$), 2011 - 2017
Figure 7‑6: United States – Forecast for AbbVie Anesthesia Drugs Sales (Million US$), 2018 – 2024
Figure 7‑7: United States – Other Companies Anesthesia Drugs Sales (Million US$), 2011 – 2017
Figure 7‑8: United States – Forecast for Other Companies Anesthesia Drugs Sales (Million US$), 2018 – 2024
Figure 11‑1: United States – Cosmetic Procedures (Number), 1997, 2012-2013, 2015-2016
Figure 11‑2: United States – Ageing Population by Age Group (Thousand), 2012 – 2016
Figure 12‑1: United States – By Region Availability of Anesthesia Specialists (Percent), 2010
Figure 12‑2: United States – By States Availability of Anesthesia Specialists (Percent), 2010
Figure 12‑3: United States – Drugs Shortage (Number), 2001-2015
Figure 12‑4: United States – Anesthesia Drugs Shortage with the Highest Frequency (Percent), 2012

List of Table:

Table 8‑1: United States – Anesthesia Market Merger & Acquisitions (M&A), Jan 2016 – March 2017
Table 9‑1: Coventry Health Care - Anesthesia Modifiers, 2016
Table 9‑2: Blue Cross and Blue Shield of Texas - Physical Status Modifiers, 2017
Table 9‑3: Blue Cross and Blue Shield of Texas - Qualifying Circumstances, 2017
Table 9‑4: Blue Cross and Blue Shield of Texas - Modifier Information Billed by an Anesthesiologist, 2017
Table 9‑5: Blue Cross and Blue Shield of Texas - Modifier Information Billed by a CRNA, 2017
Table 9‑6: Blue Cross and Blue Shield of Texas - Anesthesia Modifier Reimbursement
Table 9‑7: UnitedHealthcare Community – Modifiers, 2017
Table 10‑1: Medicare - Reimbursement Formulas
Table 10‑2: Medicare - General and Monitored Anesthesia Care
Table 10‑3: Medicare - Anesthesia Modifiers, 2017
Table 10‑4: MDwise –Type of Service & PA Requirement
Table 10‑5: MDwise - Anesthesia Time Table, 2017
Table 10‑6: MDwise - Qualifying Circumstances, 2017
Table 10‑7: MDwise - Status Modifiers, 2017
Table 11‑1: United States – Cardiovascular Disease Prevalence (Percent), 2010,2015,2020,2025, 2030

  • Global Sevoflurane Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90
    According to our LPI (LP Information) latest study, the global Sevoflurane market size was valued at US$ 1293.8 million in 2023. With growing demand in downstream market, the Sevoflurane is forecast to a readjusted size of US$ 1247.6 million by 2030 with a CAGR of -0.5% during review period. The research report highlights the growth potential of the global Sevoflurane market. Sevoflurane are expected to show stable growth in the future market. However, product differentiation, reducing c......
  • Global Remifentanil Hydrochloride Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95
    According to our LPI (LP Information) latest study, the global Remifentanil Hydrochloride market size was valued at US$ million in 2023. With growing demand in downstream market, the Remifentanil Hydrochloride is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Remifentanil Hydrochloride market. Remifentanil Hydrochloride are expected to show stable growth in the future market. How......
  • Global General Anesthesia Drugs Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 111
    According to our LPI (LP Information) latest study, the global General Anesthesia Drugs market size was valued at US$ 3840.3 million in 2023. With growing demand in downstream market, the General Anesthesia Drugs is forecast to a readjusted size of US$ 4929.3 million by 2030 with a CAGR of 3.6% during review period. The research report highlights the growth potential of the global General Anesthesia Drugs market. General Anesthesia Drugs are expected to show stable growth in the future m......
  • Global Sevoflurane Source Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90
    According to our LPI (LP Information) latest study, the global Sevoflurane Source market size was valued at US$ 1192.7 million in 2023. With growing demand in downstream market, the Sevoflurane Source is forecast to a readjusted size of US$ 1509.6 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Sevoflurane Source market. Sevoflurane Source are expected to show stable growth in the future market. However, product ......
  • Global Anesthesia Drugs Market Research Report 2023, Forecast to 2028
    Published: 26-Dec-2023        Price: US 2680 Onwards        Pages: 166
    Anesthesia is the practice of administering medicines that block the feeling of pain or other sensations to allow medical or surgical operations to take place without causing undue distress or discomfort. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while takin......
  • Global Anesthesia Drugs Professional Survey Report 2023, Forecast to 2028
    Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 108
    Anesthesia is the practice of administering medicines that block the feeling of pain or other sensations to allow medical or surgical operations to take place without causing undue distress or discomfort. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while takin......
  • Global Sevoflurane Professional Survey Report 2023, Forecast to 2028
    Published: 22-Nov-2023        Price: US 3280 Onwards        Pages: 109
    Sevoflurane is a sweet-smelling, nonflammable, highly fluorinated methyl isopropyl ether used as an inhalational anaesthetic for induction and maintenance of general anesthesia. After desflurane, it is the volatile anesthetic with the fastest onset and offset. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. T......
  • Global Sevoflurane Market Research Report 2023, Forecast to 2028
    Published: 22-Nov-2023        Price: US 2680 Onwards        Pages: 132
    Sevoflurane is a sweet-smelling, nonflammable, highly fluorinated methyl isopropyl ether used as an inhalational anaesthetic for induction and maintenance of general anesthesia. After desflurane, it is the volatile anesthetic with the fastest onset and offset. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. T......
  • Global Sevoflurane Source Market Research Report 2023, Forecast to 2028
    Published: 14-Nov-2023        Price: US 2680 Onwards        Pages: 137
    Sevoflurane Source is a sweet-smelling, nonflammable, highly fluorinated methyl isopropyl ether used as an inhalational anaesthetic for induction and maintenance of general anesthesia. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerg......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs